Clinical Trial
doi: 10.1007/BF00607671.
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions
- PMID: 324771
- DOI: 10.1007/BF00607671
Item in Clipboard
Clinical Trial
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions
Eur J Clin Pharmacol.
.
No abstract available
Similar articles
-
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.Eur J Clin Pharmacol. 1977 Apr 20;11(4):247-54. doi: 10.1007/BF00607672. Eur J Clin Pharmacol. 1977. PMID: 324772 Clinical Trial. No abstract available.
-
Effect of beta1-receptor blockade (Metoprolol, Selokenr) on blood pressure, pulse rate, plasma catecholamines, renin activity and urinary aldosterone.Acta Med Scand Suppl. 1976;602:94-6. doi: 10.1111/j.0954-6820.1977.tb07653.x. Acta Med Scand Suppl. 1976. PMID: 800317 Clinical Trial. No abstract available.
-
Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.Eur J Clin Pharmacol. 1975 Oct 10;9(1):9-19. doi: 10.1007/BF00613424. Eur J Clin Pharmacol. 1975. PMID: 9298
-
[Comparison of metroprolol and labetalol. Antihypertensive activity at rest and during exertion and effect on some noninvasive parameters of cardiovascular function].Minerva Cardioangiol. 1981 Dec;29(12):719-28. Minerva Cardioangiol. 1981. PMID: 7038536 Review. Italian. No abstract available.
-
Does physical activity lower blood pressure: a critical review of the clinical trials.J Clin Epidemiol. 1992 May;45(5):439-47. doi: 10.1016/0895-4356(92)90093-3. J Clin Epidemiol. 1992. PMID: 1588350 Review.
Cited by
-
Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.Eur J Clin Pharmacol. 1982 Oct;23(4):283-8. doi: 10.1007/BF00613607. Eur J Clin Pharmacol. 1982. PMID: 7173299
-
Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.Br J Clin Pharmacol. 1988 Feb;25(2):169-77. doi: 10.1111/j.1365-2125.1988.tb03288.x. Br J Clin Pharmacol. 1988. PMID: 2896013 Free PMC article.
-
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.Eur J Clin Pharmacol. 1977 Apr 20;11(4):247-54. doi: 10.1007/BF00607672. Eur J Clin Pharmacol. 1977. PMID: 324772 Clinical Trial. No abstract available.
-
Exercise performance and beta-blockade.Sports Med. 1985 Nov-Dec;2(6):389-412. doi: 10.2165/00007256-198502060-00002. Sports Med. 1985. PMID: 2866577 Review.
-
Effects of acute and long-term beta-adrenoceptor blockade with propranolol on haemodynamics, plasma catecholamines and renin in essential hypertension.Eur J Clin Pharmacol. 1982;23(5):377-82. doi: 10.1007/BF00605985. Eur J Clin Pharmacol. 1982. PMID: 6759143
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
